Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering high yields and simplified supply chains for API intermediates.
Patent CN113046772B details a metal-free electrochemical route for 4-selenopyrazoles, offering high yields and simplified purification for pharmaceutical supply chains.
Novel room-temperature synthesis method for phenolic compounds eliminates expensive catalysts, ensuring cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain continuity.
Novel metal-free synthesis patent CN115353482B offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN113121462B details a metal-free route to 5-trifluoromethyl-1,2,3-triazoles using diazo compounds, offering safer API intermediate manufacturing and reduced supply chain risks.
Patent CN112239384B reveals a robust carbonylation method using sulfonyl chlorides, offering cost-effective routes for high-purity thioester manufacturing.
Novel Ag2O-promoted synthesis offers significant cost reduction and scalable production capabilities for high-purity pharmaceutical intermediates targeting global supply chains.
Patent CN107382892A details a novel 4-step route for 3-aryl-4-nitroisoxazole. Offers mild conditions, high purity, and cost reduction in fine chemical manufacturing for pharma.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN111423381B reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply.
Novel Pd-catalyzed C-O coupling method for aryl esters. High yield up to 95%. Ideal for pharmaceutical intermediates. Cost-effective and scalable process.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable production for global API manufacturers.
Patent CN114634482B reveals efficient hypervalent iodine route for difluoromethyl building blocks, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering superior yields and scalable manufacturing for pharmaceutical intermediates.
Patent CN112645909B details air-stable nickel catalysis for alpha-benzylbenzofuran. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel Lewis acid catalyzed process for aromatic sulfinic acids reduces waste and energy. Reliable supply chain solution for pharmaceutical intermediate manufacturing partners.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108659028B details a novel palladium-catalyzed trans-carboboration method for synthesizing high-purity fluorochemical intermediates with improved supply chain efficiency.